Balance Sheet
Cash Flow Statement
Beginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Healthy Extracts (HYEX) Cash from Investing Activities (2016 - 2025)

Healthy Extracts' Cash from Investing Activities history spans 8 years, with the latest figure at $75603.0 for Q4 2025.

  • For Q4 2025, Cash from Investing Activities changed N/A year-over-year to $75603.0; the TTM value through Dec 2025 reached $56301.0, changed N/A, while the annual FY2025 figure was $56301.0, N/A changed from the prior year.
  • Cash from Investing Activities reached $75603.0 in Q4 2025 per HYEX's latest filing, up from -$19302.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $75603.0 in Q4 2025 to a low of -$37888.0 in Q1 2021.
  • Average Cash from Investing Activities over 3 years is -$5630.9, with a median of -$11308.0 recorded in 2021.
  • Peak YoY movement for Cash from Investing Activities: soared 69.32% in 2021, then soared 107.45% in 2022.
  • A 3-year view of Cash from Investing Activities shows it stood at -$11116.0 in 2021, then soared by 123.78% to $2643.0 in 2022, then surged by 2760.5% to $75603.0 in 2025.
  • Per Business Quant, the three most recent readings for HYEX's Cash from Investing Activities are $75603.0 (Q4 2025), -$19302.0 (Q2 2025), and $2643.0 (Q2 2022).